Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
International Journal of Biological Sciences|January 3, 2024
Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1 Inhibitor in Small-Cell Lung Cancer via GSDME/IL12/CD4Tem AxisWendi Xuzhang, Tingting Lu, Weiqiu Jin, et al.Translational Lung Cancer Research|September 21, 2020
A multicenter real-world study of tumor-derived DNA from pleural effusion supernatant in genomic profiling of advanced lung cancerShidai Jin, Chengzhi Zhou, Xue Hou, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 11, 2020
[Combination of Radiation Therapy and Immunotherapy for Non-small Cell Lung Cancer: Peer Exchange on Frontier Academic Topics], Xinghao Ai, Yong Cai, et al.Cell Death & Disease|May 18, 2023
Identification of RAC1 in promoting brain metastasis of lung adenocarcinoma using single-cell transcriptome sequencingMingyu Chen, Hanyue Li, Xiaolin Xu, et al.European Journal of Cancer (Oxford, England : 1990)|January 15, 2026
Preclinical characterization and first-in-human, phase I trial of the novel ALK inhibitor dirozalkib in advanced non-small cell lung cancerXinghao Ai, Renhua Guo, Liang Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2020
Clonal Architecture of EGFR Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641)Xinghao Ai, Jiuwei Cui, Jiexia Zhang, et al.Signal Transduction and Targeted Therapy|December 15, 2024
Noninvasive early identification of durable clinical benefit from immune checkpoint inhibition: a prospective multicenter study (NCT04566432)Xinghao Ai, Bo Jia, Zhiyi He, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 25, 2021
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 TrialShun Lu, Jie Wang, Yan Yu, et al.BMC Cancer|July 21, 2023
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapyXiaobin Zheng, Jing Lin, Jiani Xiong, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 15, 2021
Safety but Limited Efficacy of Ensartinib in ROS1-Positive NSCLC: A Single-Arm, Multicenter Phase 2 StudyXinghao Ai, Qiming Wang, Ying Cheng, et al.Pageof 4